Skip to main content
Top

Interventional Strategies for Pulmonary Artery Stenosis After the Arterial Switch Operation

Published in:

Abstract

Purpose of review

This review examines the incidence, mechanisms, and management of branch pulmonary artery stenosis following the arterial switch operation (ASO) for transposition of the great arteries. We sought to clarify how surgical techniques and anatomical factors contribute to this complication and evaluate the outcomes of different interventional strategies, including balloon angioplasty and stent implantation.

Recent Findings

Branch pulmonary artery stenosis is a frequent long-term complication after the ASO, particularly associated with the LeCompte maneuver. Advances in imaging techniques have improved detection, while transcatheter approaches represent the mainstay of treatment. Balloon angioplasty can provide short-term relief but is often limited by restenosis and external compression. Stent implantation has shown higher procedural success and lower reintervention rates, although it carries specific risks in younger patients and requires adaptation to growth.

Summary

Pulmonary artery stenosis after an ASO remains a major clinical challenge. Individualized anatomical assessment, early recognition, and tailored interventional strategies are critical for optimizing outcomes. Future research should focus on refining stent technology, hybrid techniques, and long-term surveillance to reduce complications and improve quality of life in this growing patient population.
Title
Interventional Strategies for Pulmonary Artery Stenosis After the Arterial Switch Operation
Authors
Giuliano Giusti
Ahmed Afifi
Mina Tewfik
Salim G M Jivanji
Talita Lima Ribeiro
Lee Benson
Publication date
01-12-2026
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2026
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-026-02350-y
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME